Device Trial Radar · NCT03261453
THE ENLIGHTEN STUDY
Last checked: Nov 20, 2026Latest source record: Feb 2, 2024 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
400
Actual
Start
Feb 1, 2018
Primary completion
May 1, 2019
Study completion May 1, 2019
Sponsor
- Lead sponsor
- Allurion TechnologiesNot on our public-company list
- Sponsor type
- Industry
- First posted
- Aug 25, 2017
Design
- Study type
- Interventional
- Phase
- Not applicable (typical for device studies)
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (participant, care provider, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated device
- Yes
- Who can join
- All sexes, from 22 years, up to 65 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The primary objective of this study is to demonstrate the safety and efficacy of the Elipse Gastric Balloon System for the treatment of obese adults.
Conditions
- Obesity
- Overweight
Interventions
Active Elipse DeviceDevice
Intervention Device
Elipse Sham DeviceDevice
Control Device
Primary outcomes
What the sponsor says the trial is designed to measure.
- Co-Primary Effectiveness Endpoint: Total Body Weight Loss (TBWL) Comparison Between Treatment and Control Group at 16 weeksTime frame: 16 weeks
- Co-Primary Effectiveness Endpoint 2: Percent of Total Body Weight Loss (TBWL) Comparison Between Treatment and Control groupTime frame: 16 weeks
- Primary Safety Endpoint: Incidence of overall procedure or device related Serious Adverse EventsTime frame: 24 weeks
Locations
12 sites in 1 country. Site status is shown where the registry gives one.
Honor Health
Scottsdale, Arizona
University of Colorado, Anschutz Health and Wellness Center
Aurora, Colorado
Bariatric Institute of Greater Chicago
Bolingbrook, Illinois
9 more study sites with a free account
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.